BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schiffer JT, Gottlieb SL. Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development. Vaccine 2019;37:7363-71. [PMID: 28958807 DOI: 10.1016/j.vaccine.2017.09.044] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Yan Y, Hu K, Fu M, Deng X, Guan X, Luo S, Zhang M, Liu Y, Hu Q. CCL28 Enhances HSV-2 gB-Specific Th1-Polarized Immune Responses against Lethal Vaginal Challenge in Mice. Vaccines 2022;10:1291. [DOI: 10.3390/vaccines10081291] [Reference Citation Analysis]
2 Cazorla-Luna R, Ruiz-Caro R, Veiga MD, Malcolm RK, Lamprou DA. Recent advances in electrospun nanofiber vaginal formulations for women's sexual and reproductive health. Int J Pharm 2021;607:121040. [PMID: 34450222 DOI: 10.1016/j.ijpharm.2021.121040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Getz M, Wang Y, An G, Asthana M, Becker A, Cockrell C, Collier N, Craig M, Davis CL, Faeder JR, Versypt ANF, Mapder T, Gianlupi JF, Glazier JA, Hamis S, Heiland R, Hillen T, Hou D, Islam MA, Jenner AL, Kurtoglu F, Larkin CI, Liu B, Macfarlane F, Maygrundter P, Morel PA, Narayanan A, Ozik J, Pienaar E, Rangamani P, Saglam AS, Shoemaker JE, Smith AM, Weaver JJA, Macklin P. Iterative community-driven development of a SARS-CoV-2 tissue simulator. bioRxiv 2021:2020. [PMID: 32511322 DOI: 10.1101/2020.04.02.019075] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 13.0] [Reference Citation Analysis]
4 Shao DD, Meng FZ, Liu Y, Xu XQ, Wang X, Hu WH, Hou W, Ho WZ. Poly(dA:dT) Suppresses HSV-2 Infection of Human Cervical Epithelial Cells Through RIG-I Activation. Front Immunol 2020;11:598884. [PMID: 33664729 DOI: 10.3389/fimmu.2020.598884] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Donalisio M, Argenziano M, Rittà M, Bastiancich C, Civra A, Lembo D, Cavalli R. Acyclovir-loaded sulfobutyl ether-β-cyclodextrin decorated chitosan nanodroplets for the local treatment of HSV-2 infections. International Journal of Pharmaceutics 2020;587:119676. [DOI: 10.1016/j.ijpharm.2020.119676] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
6 Yi M, Lin S, Zhang B, Jin H, Ding L. Antiviral potential of natural products from marine microbes. Eur J Med Chem 2020;207:112790. [PMID: 32937282 DOI: 10.1016/j.ejmech.2020.112790] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
7 Issakwisa HM, Mbwile GR, Mbwanji GF, Nassoro DD, Ntinginya NE, Nsojo AA. Seroprevalence of herpes simplex virus type 1 among people living with HIV in Mbeya, Tanzania. BMC Infect Dis 2020;20:577. [PMID: 32758172 DOI: 10.1186/s12879-020-05301-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Maslova AA, Matyugina ES, Snoeck R, Andrei G, Kochetkov SN, Khandazhinskaya AL, Novikov MS. Uracil-Containing Heterodimers of a New Type: Synthesis and Study of Their Anti-Viral Properties. Molecules 2020;25:E3350. [PMID: 32717979 DOI: 10.3390/molecules25153350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Engmann C, Fleming JA, Khan S, Innis BL, Smith JM, Hombach J, Sobanjo-Ter Meulen A. Closer and closer? Maternal immunization: current promise, future horizons. J Perinatol 2020;40:844-57. [PMID: 32341454 DOI: 10.1038/s41372-020-0668-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
10 van Velthoven MH, Lam C, de Cock C, Stenfors T, Chaudhury H, Meinert E. Development of an Innovative Real-World Evidence Registry for the Herpes Simplex Virus: Case Study. JMIR Dermatol 2020;3:e16933. [DOI: 10.2196/16933] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
11 Looker KJ, Johnston C, Welton NJ, James C, Vickerman P, Turner KME, Boily MC, Gottlieb SL. The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study. BMJ Glob Health 2020;5:e001875. [PMID: 32201620 DOI: 10.1136/bmjgh-2019-001875] [Cited by in Crossref: 8] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
12 Looker KJ, Welton NJ, Sabin KM, Dalal S, Vickerman P, Turner KME, Boily MC, Gottlieb SL. Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence: a population attributable fraction analysis using published epidemiological data. Lancet Infect Dis 2020;20:240-9. [PMID: 31753763 DOI: 10.1016/S1473-3099(19)30470-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 38] [Article Influence: 10.3] [Reference Citation Analysis]
13 Duan Q, Liu T, Yuan P, Huang C, Shao Q, Xu L, Sun J, Huang G, Chen Z. Antiviral effect of Chinese herbal prescription JieZe-1 on adhesion and penetration of VK2/E6E7 with herpes simplex viruses type 2. J Ethnopharmacol 2020;249:112405. [PMID: 31743766 DOI: 10.1016/j.jep.2019.112405] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
14 Richert-Spuhler LE, Pattacini L, Plews M, Irungu E, Muwonge TR, Katabira E, Mugo N, Meyers AFA, Celum C, Baeten JM, Lingappa JR, Lund JM. Pre-exposure prophylaxis differentially alters circulating and mucosal immune cell activation in herpes simplex virus type 2 seropositive women. AIDS 2019;33:2125-36. [PMID: 31335802 DOI: 10.1097/QAD.0000000000002323] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Van Wagoner N, Fife K, Leone PA, Bernstein DI, Warren T, Panther L, Novak RM, Beigi R, Kriesel J, Tyring S, Koltun W, Lucksinger G, Morris A, Zhang B, McNeil LK, Tasker S, Hetherington S, Wald A. Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital Herpes Simplex Virus-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-Controlled Trial. J Infect Dis 2018;218:1890-9. [PMID: 29982727 DOI: 10.1093/infdis/jiy415] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
16 Schiffer JT, Swan DA, Prlic M, Lund JM. Herpes simplex virus-2 dynamics as a probe to measure the extremely rapid and spatially localized tissue-resident T-cell response. Immunol Rev 2018;285:113-33. [PMID: 30129205 DOI: 10.1111/imr.12672] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
17 de-la-Torre A. Virus-Induced Anterior Uveitis (VIAU) in Immunocompromised Patients. Ocul Immunol Inflamm 2018;26:807-17. [PMID: 29969370 DOI: 10.1080/09273948.2018.1483519] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Szymańska E, Orłowski P, Winnicka K, Tomaszewska E, Bąska P, Celichowski G, Grobelny J, Basa A, Krzyżowska M. Multifunctional Tannic Acid/Silver Nanoparticle-Based Mucoadhesive Hydrogel for Improved Local Treatment of HSV Infection: In Vitro and In Vivo Studies. Int J Mol Sci 2018;19:E387. [PMID: 29382085 DOI: 10.3390/ijms19020387] [Cited by in Crossref: 26] [Cited by in F6Publishing: 35] [Article Influence: 6.5] [Reference Citation Analysis]